Literature DB >> 32785645

The V369M Gcgr knock-in mice are a precision medicine model of mild Mahvash disease.

Run Yu1.   

Abstract

The detailed metabolic characterization of the glucagon receptor (Gcgr)V369M+/+ mutant mice described in Lin et al. in the Biochemical Journal is of interest and resulting in the expected metabolic profile. We would like to point out that these mice might also be extremely useful as a precision medicine model of mild Mahvash disease, a rare hereditary pancreatic neuroendocrine tumor syndrome characterized by inactivating mutations in the glucagon receptor. Further characterization of pancreas morphology and histology in the GcgrV369M+/+ mice at more advanced ages will be critically important to understand mild Mahvash disease in humans.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Mahvash disease; glucagon receptor; mutation

Year:  2020        PMID: 32785645     DOI: 10.1042/BCJ20200522

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  2 in total

1.  Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis.

Authors:  Qiaofeng Liu; Guangyao Lin; Yan Chen; Wenbo Feng; Yingna Xu; Jianjun Lyu; Dehua Yang; Ming-Wei Wang
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 2.  Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes.

Authors:  Yunbo Jia; Yang Liu; Linlin Feng; Siyu Sun; Guangwei Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.